Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NeoStem: Catalysts Upcoming, Financing In Rear View Mirror
Seeking Alpha
Monday, October 28, 2013 - 3:18pm
tags:
NeoStem, AMR-101
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Monday, October 28, 2013 - 12:10pm
tags:
Bristol-Myers Squibb, nivolumab, lung cancer
Is Glaxo Keeping Its Commitment To Releasing Paxil Trial Data?
Pharmalot
Monday, October 28, 2013 - 12:04pm
tags:
GSK, Paxil, clinical trial data
Dendreon Buyout? Don't Get Too Excited
Seeking Alpha
Monday, October 28, 2013 - 12:03pm
tags:
Dendreon, M&A
DARA Raises Cash, Expands Sales Force
Seeking Alpha
Monday, October 28, 2013 - 12:03pm
tags:
DARA Biosciences, Alamo Pharma Services, Soltamox, Gelcair, Bionect
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Monday, October 28, 2013 - 10:26am
tags:
patents, Copaxone, Teva, Nexium, AstraZeneca, Micardis, Boehringer Ingelheim, Sandostatin LAR, Novartis, Exforge, Nasonex, Merck, TriLipix, AbbVie, Evista, Eli Lilly, Restasis, Allergan, Renagel, Sanofi
3 Diagnostic Stocks That May See Sales Soar Because of Obamacare
Motley Fool
Monday, October 28, 2013 - 10:23am
tags:
Affordable Care Act, diagnostics, Intuitive Surgical, OraSure, Sequenom
Philips, Infraredx ink resale deal
Mass Device
Monday, October 28, 2013 - 10:22am
tags:
devices, Philips, InfraReDx, TVC imaging
The Questionable Dendreon Buyout Incentive
Yahoo/Wall St 24-7
Monday, October 28, 2013 - 9:57am
tags:
Dendreon, Provenge, M&A
Edwards Lifesciences earnings rise
Reuters
Monday, October 28, 2013 - 9:53am
tags:
Edwards Lifesciences, earnings
Time Is No Friend To Synta's Lung Cancer Drug
TheStreet.com
Monday, October 28, 2013 - 9:52am
tags:
Synta Pharmaceuticals, lung cancer, ganetespib
Zogenix shares climb in first trading day after FDA approves extended-release painkiller
Yahoo/AP
Monday, October 28, 2013 - 9:51am
tags:
FDA, Zogenix, Zohydro ER, painkillers
Dendreon, Zogenix, and Ampio Pharmaceuticals Could Be Big Movers Today
Motley Fool
Monday, October 28, 2013 - 9:33am
tags:
Dendreon, Zogenix, Ampio Pharmaceuticals, prostate cancer, Medivation, Zytiga, Provenge, Zohydro ER, Ampion
J&J Is Curiously Absent From Twitter -- Does That Matter?
Advertising Age
Monday, October 28, 2013 - 9:31am
tags:
JNJ, twitter, social media
Novo Nordisk Recalls FlexPen, Penfill Insulin in Europe
Bloomberg
Monday, October 28, 2013 - 9:30am
tags:
Novo Nordisk, recalls, Europe, insulin pen, insulin, diabetes, Penfill, FlexPen
What Might Amarin Be Worth to GlaxoSmithKline or Others?
Motley Fool
Monday, October 28, 2013 - 9:29am
tags:
Amarin, GSK, M&A, Vascepa
Teva Pharm denies report CEO mulling resignation over rift
Yahoo/Reuters
Monday, October 28, 2013 - 9:26am
tags:
Teva, Pharma CEOs, Jeremy Levin
Biogen's new MS drug tops sales expectations, earnings rise
Yahoo/Reuters
Monday, October 28, 2013 - 8:35am
tags:
Biogen Idec, earnings
Merck Profit Beats Analysts’ Estimates on Gardasil Sales
Bloomberg
Monday, October 28, 2013 - 8:32am
tags:
Merck, earnings
Actelion’s Drug Approval Seen Enticing Buyers: Real M&A
Bloomberg
Monday, October 28, 2013 - 8:32am
tags:
M&A, Actelion, Opsumit, Bayer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.